Fiche publication


Date publication

novembre 2020

Journal

Current opinion in oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Dr EBERST Lauriane


Tous les auteurs :
Eberst L, Bailleux C, Bachelot T

Résumé

For patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer, treatments that could prevent or delay occurrence of brain metastases would improve outcome.

Mots clés

Brain Neoplasms, enzymology, Breast Neoplasms, drug therapy, Clinical Trials, Phase III as Topic, Cranial Irradiation, Female, Humans, Protein Kinase Inhibitors, pharmacology, Randomized Controlled Trials as Topic, Receptor, ErbB-2, antagonists & inhibitors

Référence

Curr Opin Oncol. 2020 11;32(6):555-560